Pharmabiz8h
Bioretec inks sales and distribution pact to speed-up the commercialization of RemeOs Trauma Screw in US market
Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopaedic implants, is moving ahead with the next phase of the commercialization of its innovative RemeOs Trauma Products in ...
Pharmabiz4h
Lipella Pharma completes dosing for first cohort in phase 2a trial of LP-310 for oral lichen planus
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company focused on innovative therapies for serious diseases with significant unmet needs, announced the completion of dosing for the first ...
Pharmabiz13h
Japan’s MHLW grants expanded indication approval to GSK’s RSV vaccine, Arexvy for adults aged 50-59 at increased risk of severe RSV disease
GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus vaccine, recombinant ...
Pharmabiz7h
China NMPA approves Merck’s Welireg to treat adult patients with certain types of von Hippel-Lindau disease-associated tumours
Merck, known as MSD outside of the United States and Canada, announced that the National Medical Products Administration (NMPA) in China has approved Welireg (belzutifan), for the treatment of adult ...
Pharmabiz6h
SOPHiA GENETICS launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
SOPHiA GENETICS, a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT powered with SOPHiA DDM from the Association for Molecular Pathology ...
Pharmabiz11h
Zai Lab, Pfizer enter collaboration on novel antibacterial drug Xacduro in mainland China
Zai Lab (Zai Lab) and Pfizer announced a strategic collaboration for the novel antibacterial drug Xacduro (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated companies will be exclusively ...
Pharmabiz18h
Zenyaku Kogyo receives Japanese approval for anti-CD20 monoclonal antibody, Rituxan to treat chronic ITP in children
Zenyaku Kogyo receives Japanese approval for anti-CD20 monoclonal antibody, Rituxan to treat chronic ITP in children: Tokyo Saturday, November 23, 2024, 10:00 Hrs [IST] Zenyaku Ko ...
Pharmabiz11h
CapeStart introduces MadeAi, a GenAI-enabled platform for life sciences that transforms literature review and other applications
CapeStart introduces MadeAi, a GenAI-enabled platform for life sciences that transforms literature review and other applications: Barcelona, Spain Saturday, November 23, 2024, 17: ...
Pharmabiz16h
Leads Biolabs receives US FDA orphan drug designation for anti-PD-L1/4-1BB bispecific antibody, LBL-024 for treatment of neuroendocrine cancer
Leads Biolabs receives US FDA orphan drug designation for anti-PD-L1/4-1BB bispecific antibody, LBL-024 for treatment of neuroendocrine cancer: Nanjing, China Saturday, November 2 ...
Pharmabiz15h
Philips introduces next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading
Philips introduces next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading: Amsterdam, the Netherlands Saturday, November 23, 2024, 13:00 Hrs [IS ...
Pharmabiz20h
Expert highlights the critical role of X-ray and PFT machines in improving the diagnosis of COPD
Expert highlights the critical role of X-ray and PFT machines in improving the diagnosis of COPD: Shardul Nautiyal, Mumbai Saturday, November 23, 2024, 08:00 Hrs [IST] As the awar ...
Pharmabiz20h
Biotechnology to spur avenues in precision bio-therapeutics & bio-based chemicals
Biotechnology to spur avenues in precision bio-therapeutics & bio-based chemicals: Nandita Vijayasimha, Bengaluru Saturday, November 23, 2024, 08:00 Hrs [IST] Union government is ...